Adaptation of Cognitive Enhancement Therapy for persons at Psychosis High Risk
Adaptation of Cognitive Enhancement Therapy for persons at Psychosis High Risk
批准号:
8976169
负责人:
MATCHERI S. KESHAVAN
金额:
$26.1万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-12-01 至 2017-11-30
关键词:
AddressAdolescent DevelopmentAdultAntipsychotic AgentsAttentionAttenuatedCaringChronicClinicalCognitionCognitive TherapyCognitive remediationCommunitiesDataDeteriorationDevelopmentDoseEarly InterventionFamilyFatty AcidsFocus GroupsGoalsHealthImpaired cognitionImpairmentIndividualInnovative TherapyInterventionIntervention StudiesLearningManualsMemoryMeta-AnalysisNeuronal PlasticityOmega-3 Fatty AcidsParticipantPersonsPhasePopulationPrevention approachProceduresPsychopathologyPsychotic DisordersPublic HealthRandomized Controlled TrialsRecruitment ActivityResearchSchizophreniaSpeedSupervisionSymptomsTechniquesTestingTrainingadverse outcomebaseclinical practicecognitive disabilitycognitive enhancementexecutive functionexperiencefunctional disabilityfunctional outcomesgray matterhigh riskimprovedindicated preventionnovelopen labelpsychiatric symptompsychosocialsocialsocial cognitionsocial situationtraittreatment adherencetreatment response
中文摘要
描述(由申请人提供):处于精神病临床高危状态的人的特征是精神病发作减弱或短暂,性格脆弱和功能
赤字。如果不治疗,相当大比例的慢性阻塞性肺病患者会产生不良后果,包括转化为精神病、其他精神病理学和功能退化。尽管在过去十年中加强了对CHR的研究,但几乎没有既定的预防方法。这项建议旨在开发、评估可行性和可接受性,并获得关于认知增强的新方法的初步数据,该方法是一种用于认知增强的新方法,用于学习和理解日常社交情况(线索),适用于临床高危精神病患者。这一方法是基于认知增强疗法(CET)的原理和方法,该研究小组表明,CET具有有效性、对功能结果的概括性、持久性和可能的神经保护作用。
在第一阶段(0-6个月),我们将使CET技术适应CHR的症状、功能和发育特征,培训工作人员,并在焦点小组和专家咨询小组的帮助下制定评估程序和线索干预手册。在第二阶段,使用可行性试验(n=8),我们将评估可接受性、耐受性、治疗依从性、治疗忠诚度,并获得目标参与的初步证据(即认知和社会认知的变化)。在第三阶段(19-36个月),我们将进行一项随机对照试验,以产生关于慢性阻塞性肺疾病患者(n=30)线索的飞行员疗效、对功能结果的概化、耐受性和耐受性数据。这些数据将作为以后对CHR人群中的线索进行更大规模的干预性研究的先决条件。
英文摘要
DESCRIPTION (provided by applicant): Persons at clinical high risk (CHR) state for psychosis are characterized by attenuated or transient psychotic episodes, trait vulnerability and functional
deficits. If untreated, a significant proportion of CHR individuals have adverse outcomes, including conversion to psychosis, other psychopathology and functional deterioration. Despite enhanced CHR research focus over the past decade there are few established prevention approaches. This proposal seeks to develop, evaluate feasibility, acceptability and obtain preliminary data on efficacy of a novel manualized approach for cognitive enhancement, the Cognition for Learning and for Understanding Everyday Social Situations (CLUES) in individuals at clinical high risk (CHR) for psychosis. This approach is based on the principles and approaches of cognitive enhancement therapy (CET), shown by this research group to have efficacy, generalizability to functional outcome, durability and possible neuroprotective effects.
In Phase 1 (0-6 months) we will adapt CET techniques to the symptomatic, functional, and developmental features of CHR, train staff and develop assessment procedures and a manual for the CLUES intervention with the help of a focus group and input from an advisory group of experts. In phase 2, using a feasibility trial (n=8) we will assess acceptability, tolerability, treatment adherence, treatment fidelity, and obtain preliminary evidence of target engagement (i.e. change in cognition and social cognition). .In Phase 3 (19-36 months) we will conduct a randomized control trial to generate pilot efficacy, generalization to functional outcome, durability and tolerability data on CLUES in CHR individuals (n=30). These data will serve as a prerequisite to a later, larger-scale intervention study of CLUES in the CHR population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)
-
批准号:10683233
-
项目类别:
-
资助金额:$25.91万
-
财政年份:2022
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
-
批准号:10396433
-
项目类别:
-
资助金额:$27.51万
-
财政年份:2021
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
-
批准号:10613507
-
项目类别:
-
资助金额:$27.5万
-
财政年份:2021
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Longitudinal trajectories in treated and untreated schizophrenia
-
批准号:10306962
-
项目类别:
-
资助金额:$64.17万
-
财政年份:2021
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Characterizing cognition across the lifespan in untreated psychosis in China
-
批准号:9403816
-
项目类别:
-
资助金额:$60.26万
-
财政年份:2015
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Sleep spindles in early course schizophrenia and first-degree relatives
-
批准号:9139499
-
项目类别:
-
资助金额:$62.48万
-
财政年份:2015
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Sleep spindles in early course schizophrenia and first-degree relatives
-
批准号:9702857
-
项目类别:
-
资助金额:$55.46万
-
财政年份:2015
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/6 Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)
-
批准号:8506547
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2013
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/6 Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)
-
批准号:8706965
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2013
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8453355
-
项目类别:
-
资助金额:$60.08万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8644914
-
项目类别:
-
资助金额:$60.76万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8236770
-
项目类别:
-
资助金额:$67.46万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8831006
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
CORE--CLINICAL
-
批准号:7553455
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes
-
批准号:9293368
-
项目类别:
-
资助金额:$56.47万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
-
批准号:7668419
-
项目类别:
-
资助金额:$80.15万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
-
批准号:7917305
-
项目类别:
-
资助金额:$77.04万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
-
批准号:7384973
-
项目类别:
-
资助金额:$80.95万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
EFFECT OF QUETIAPINE ON DELTA SLEEP DEFICITS IN SCHIZOPHRENIA
-
批准号:7201198
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
BRAIN CIRCUITRY AND COGNITION IN PSYCHOSIS
-
批准号:7201211
-
项目类别:
-
资助金额:$2.3万
-
财政年份:2005
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
海外基金